Skip to content

Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention

Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05933122
Acronym
RectSexQol
Enrollment
144
Registered
2023-07-06
Start date
2024-04-03
Completion date
2027-10-31
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Tumor, Women, Sexuality, Life Quality

Keywords

rectal cancer, women, sexuality, quality of life

Brief summary

RectSexQoL is a study aiming at determining the prevalence of female sexual dysfunction after rectal cancer surgery. It has the goal as well to analyse the impact of an intervention given by a sexologist to such patients.

Detailed description

The treatment of rectal cancer is multimodal combining surgery, chemotherapy and radiotherapy. Each therapeutic tool may affect the sexual life of treated patients. The incidence of sexual dysfunction in patients with rectal cancer varies according to literature from 5 to 88%. This may be due to the lack of a common definition relating to sexual dysfunction making it difficult to compare results. On the other hand, it should be noted that all of the work related to sexual dysfunction after treatment for rectal cancer is mainly interested in men. The sexual well-being of women treated for rectal cancer is based on the assessment and management of their sexual functions as well as that of their overall sexual health in a personalized manner. The establishment of a sexology consultation before and after such a surgical procedure could improve the sexual functions as well as the sexual well-being of these women. The main aim of our study is to evaluate the prevalence of sexual dysfunctions at M-1 (before treatment) in the two cohorts here and elsewhere in the context of surgery for rectal cancer in females. The second aim will be to determine the impact of sexology consultation in the cohort here in comparison to the standart cohort without any intervention called elsewhere.

Interventions

OTHERsexologist consult

in the cohort called here, after the diagnosis of rectal cancer, patients will be seen by a sexologist before any kind of treatment for rectal cancer. Sexual dysfunctions will be assessed by a sexologist. After the surgery of rectal cancer, the sexologist will see them again to assess sexual dysfunctions after such a management of rectal cancer. If there is any discovery of a sexual dysfunction or aggravation of a previous one or alteration of sexual life, the sexologist will help the patients to improve their sexual quality of life.

in the cohort called elsewhere , patients will be treated according to standards of care, without specific care by a sexologist

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

* Cohort called elsewhere = cohort without specific care by a sexologist * Cohort called here = cohort with an intervention by a sexologist

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women * Diagnosis of stage I-III rectal adenocarcinoma or rectosigmoid junction with anastomosis less than 15 cm from the anal margin * Surgical management, preceded or not by Radio-chemotherapy, with restoration of continuity * Age : over 18 * Proficiency in French or English

Exclusion criteria

* Current pregnancy * Significant cognitive/psychiatric disorders * Guardianship

Design outcomes

Primary

MeasureTime frameDescription
Number and proportion of women with sexual dysfunction defined as a total FSFIMonth -1Number and proportion of women with sexual dysfunction defined as a total FSFI (Female Sexual Function Index) score greater than 26.55 at Month -1 (before any treatment) in the context of surgery for rectal cancer

Secondary

MeasureTime frameDescription
Number and proportion of women with sexual dysfunction defined as a total FSFI score greater than 26.55 at Month 6 and Month 12 after usual or specific management in the context of surgery for rectal cancerMonth 12Number and proportion of women with sexual dysfunction defined as a total FSFI (Female Sexual Function Index) score greater than 26.55 at Month 6 and Month 12 after usual (elsewhere cohort) or specific management (duration of 6 months) (here cohort, including consultations by a sexologist supervising the surgical procedure) in the context of surgery for rectal cancer
Change in the score of the satisfaction dimension of the FSFI scale between Month -1, Month 6 and Month 12Month 12Change in the score of the satisfaction dimension of the FSFI scale between Month -1, Month 6 and Month 12
Differences (Month 6 - Month -1 and Month 12 - Month 6) in the score of the satisfaction dimension of the FSFI scale (Q14-Q16) between the groups with and without treatment by a sexologist (cohort here vs. elsewhere)Month 12Differences (Month 6 - Month -1 and Month 12 - Month 6) in the score of the satisfaction dimension of the FSFI scale (Q14-Q16) between the groups with and without treatment by a sexologist (cohort here vs. elsewhere)

Countries

France

Contacts

Primary ContactNiki Christou, MD
christou.niki19@gmail.com+335 55 05 67 30

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026